Please login to the form below

Not currently logged in
Email:
Password:

Pascale Richetta moves from AbbVie to UCB

She joins the biopharmaceutical company as executive vice president
Pascale Richetta

UCB has appointed Pascale Richetta to lead the global biopharmaceutical company's new bone patient value unit with effect from 1 February.

The unit was created last year with the development of UCB's patient value organisation and is currently led by its chief medical officer and head of the development of medical practices Iris Loew Friedrich.

In her new role Richetta will also serve at UCB as an executive vice president and member of the Belgium-based company's executive committee.

She has over 20 years of commercial and managerial experience in the pharmaceutical industry having worked with both traditional pharmaceuticals and complex biologics.

Richetta most recently served as vice president for Western Europe and Canada for AbbVie.

Prior to this, Richetta held managerial positions at Abbott, GSK, Ipsen and Servier where she was responsible for the international launch of each company's key drugs.

21st January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics